Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders

Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Hematology signal an important step forward in the development of treatment strategies for patients with hard-to-treat leukemia, myeloma, and myelofibrosis.

http://www.innovations-report.com/html/reports/medicine_health/therapeutic_agents_provide_hope_patients_hard_treat_206982.html